Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients

Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials